ditert-butyl-(5-ditert-butylphosphanyl-9,9-dimethylxanthen-4-yl)phosphane

We are ditert-butyl-(5-ditert-butylphosphanyl-9,9-dimethylxanthen-4-yl)phosphane CAS:856405-77-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: ditert-butyl-(5-ditert-butylphosphanyl-9,9-dimethylxanthen-4-yl)phosphane
CAS.NO:856405-77-1
Molecular Formula:C31H48OP2
Molecular Weight:498.66000

Synonyms:
t-Bu-Xantphos
9,9-Dimethyl-4,5-bis(di-tert-butylphosphino)xanthene
4,5-Bis(di-tert-butylphosphino)-9,9-dimethylxanthene

Physical and Chemical Properties:
Density: /
Boiling point: 563.1±50.0 °C
Melting point:153-157℃
Flash point: /
Refractive index: /

Specification:
Appearance:white to light yellow  powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

ditert-butyl-(5-ditert-butylphosphanyl-9,9-dimethylxanthen-4-yl)phosphane


Related News: Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.17114-97-5 In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.2-Naphthaleneboronic acid CAS:32316-92-0 The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexene-1-carboxaldehyde CAS:1228837-05-5 Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase.The news comes after China’s National Health Commission issued a notice on the treatment of the coronavirus on Monday, asking medical institutions to “actively promote the role of traditional Chinese medicine (TCM) during treatment.”

Related Products
Product Name
n-tert-butylacrylamide Cas:107-58-4 View Details
1-[3-(2-aminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide View Details
5-[2-(DIETHYLAMINO)ETHYL]-3-PHENYL-1,2,4-OXADIAZOLE CITRATE SALT Cas:1949-20-8 View Details
Hexafluorozirconic Acid manufacturer 3-(Methylamino)piperidine Dihydrochloride manufacturer 1,1,1,2,3,3,3-Heptafluoropropane Cas:431-89-0 manufacturer Phenyltris(methylethylketoximio)silane manufacturer Diethylene Triamine Penta (Methylene Phosphonic Acid) manufacturer